Basal Insulin Initiation for A1C 10% on Maximal Metformin
Start basal insulin at 10 units daily OR 0.1-0.2 units/kg/day, continuing metformin, and titrate by 2 units every 3 days until fasting plasma glucose reaches target. 1
Rationale for This Approach
With an A1C of 10%, this patient meets the threshold where insulin is explicitly recommended by the 2025 ADA Standards of Care 1. The guidelines specifically state that insulin should be considered as the first injectable when A1C is ≥10% (≥86 mmol/mol), particularly after oral agents have been optimally used 1.
Specific Insulin Regimen
Initial Dosing
- Start with basal insulin analog or bedtime NPH: 10 units per day OR 0.1-0.2 units/kg per day 1
- Continue metformin: This combination reduces weight gain, lowers total insulin requirements, and decreases hypoglycemia risk compared to insulin alone 1
Titration Protocol
- Set an individualized fasting plasma glucose goal (typically 80-130 mg/dL for most adults)
- Increase by 2 units every 3 days to reach fasting glucose target without hypoglycemia 1
- For hypoglycemia: identify the cause; if no clear reason exists, lower dose by 10-20% 1
Choice of Basal Insulin
The selection between basal insulin analogs (glargine, detemir, degludec) versus NPH should be based on:
- Cost considerations (NPH is typically less expensive)
- Hypoglycemia risk (analogs have lower nocturnal hypoglycemia rates)
- Patient preference and adherence (once-daily vs twice-daily dosing)
Consider prescribing glucagon for emergent hypoglycemia 1.
Why Continue Metformin
Do not discontinue metformin when starting insulin 1. The evidence strongly supports continuing metformin because:
- It reduces all-cause mortality and cardiovascular events in overweight patients with diabetes 2
- It decreases weight gain associated with insulin therapy 1
- It lowers total insulin dose requirements 1
- Abrupt discontinuation risks rebound hyperglycemia 3
Monitoring and Reassessment
- Use fasting plasma glucose values to titrate basal insulin 1
- Assess insulin dose adequacy at every visit (typically every 3-6 months) 1
- Watch for signs of overbasalization: elevated bedtime-to-morning glucose differential, postprandial hyperglycemia, hypoglycemia, or high glucose variability 1
When to Intensify Further
If A1C remains above goal after optimizing basal insulin:
- First consideration: Add a GLP-1 receptor agonist or dual GIP/GLP-1 agonist if not already prescribed (may use fixed-ratio combination product) 1
- If still inadequate: Add prandial insulin, starting with one dose at the largest meal (4 units or 10% of basal dose) 1
Common Pitfalls to Avoid
- Therapeutic inertia: Don't delay insulin initiation when clearly indicated at A1C ≥10% 1
- Stopping metformin: This increases weight gain and insulin requirements unnecessarily 1, 2
- Inadequate titration: Many patients remain undertreated; use systematic titration protocols 1
- Ignoring injection technique: Use 4-6mm needles to avoid intramuscular injection, which can cause severe hypoglycemia; rotate sites to prevent lipohypertrophy 3